Author

M. Mohsen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:variant effect prediction· 1 Organism:virus· 1

Frequent Co-Authors

M. F. Bachmann· 2 shared M. Vogel· 2 shared X. Chang· 2 shared A.-C. S. Vogt· 1 shared B. Martina· 1 shared D. E. Speiser· 1 shared G. Augusto· 1 shared G. Nasrallah· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. F. Bachmann

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Increased receptor affinity and reduced recognition by specific antibodies contribute to immune escape of SARS-CoV-2 variant Omicron

A.-C. S. Vogt, G. Augusto, B. Martina, X. Chang, G. Nasrallah, D. E. Speiser, M. Vogel, M. F. Bachmann, M. Mohsen

This study shows that SARS-CoV-2 Omicron escapes neutralizing antibodies through increased receptor affinity and reduced antibody recognition, while vaccines still provide some neutralization.

bioRxiv · Mar 11, 2022Immunology

BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection but recognition of mutant viruses is up to 10-fold reduced

M. Mohsen, M. F. Bachmann, M. Vogel, G. S. Augusto, X. Liu, X. Chang

This study compares antibody recognition of SARS-CoV-2 variants by natural infection and BNT162b2 vaccination, finding improved but reduced cross-reactivity against certain mutants.

bioRxiv · Mar 13, 2021Immunology